Logo-apb

Read This Article

Article History

Submitted: 18 Apr 2022
Revision: 17 Jul 2023
Accepted: 08 Oct 2023
ePublished: 14 Oct 2023

  Google Scholar Profile

PubMed Profile

Share This Article!

Export Citation

EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Cited By

Adv Pharm Bull. 2024;14(1): 7-8.
doi: 10.34172/apb.2024.017
PMID: 38585466
PMCID: PMC10997940
  Abstract View: 1083
  PDF Download: 828
  Full Text View: 300

Letter to Editor

Can Intranasal Insulin and Cholinergic Agonist Improve Post-Covid-19 Cognition Impairment?

Amr Ahmed 1* ORCID logo, Mahmoud El Kazzaz 2 ORCID logo, Aml M. Brakat 3 ORCID logo

1 Department of Public Health, Tuberculosis Program, First Health Cluster, Ministry of Health, Riyadh, Saudi Arabia.
2 Department of Chemistry and Biochemistry, Faculty of Science, Damietta University, Egypt.
3 Faculty of Medicine, Zagazig University, Egypt.
*Corresponding Author: Amr Ahmed, Email: drmedahmed@gmail.com
First Name
Last Name
Email Address
Comments
Security code


Abstract View: 1084

Your browser does not support the canvas element.

PDF Download: 828

Your browser does not support the canvas element.

Full Text View: 300

Your browser does not support the canvas element.